Novavax (NVAX) Convertible Debt (2016 - 2025)
Novavax (NVAX) has 10 years of Convertible Debt data on record, last reported at $244.2 million in Q4 2025.
- For Q4 2025, Convertible Debt rose 43.92% year-over-year to $244.2 million; the TTM value through Dec 2025 reached $244.2 million, up 43.92%, while the annual FY2025 figure was $244.2 million, 43.92% up from the prior year.
- Convertible Debt reached $244.2 million in Q4 2025 per NVAX's latest filing, roughly flat from $243.8 million in the prior quarter.
- Across five years, Convertible Debt topped out at $324.5 million in Q3 2022 and bottomed at $166.5 million in Q4 2022.
- Average Convertible Debt over 5 years is $230.3 million, with a median of $170.3 million recorded in 2025.
- Peak YoY movement for Convertible Debt: plummeted 48.54% in 2022, then soared 44.06% in 2025.
- A 5-year view of Convertible Debt shows it stood at $323.5 million in 2021, then crashed by 48.54% to $166.5 million in 2022, then grew by 0.93% to $168.0 million in 2023, then increased by 0.99% to $169.7 million in 2024, then surged by 43.92% to $244.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Convertible Debt were $244.2 million in Q4 2025, $243.8 million in Q3 2025, and $170.6 million in Q2 2025.